The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression
- PMID: 19229865
- DOI: 10.1002/jcb.22087
The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression
Abstract
The metalloproteinase ADAM15 is a multi-domain disintegrin protease that is upregulated in a variety of human cancers. ADAM15 mRNA and protein levels are increased in prostate cancer and its expression is significantly increased during metastatic progression. It is likely that ADAM15 supports disease progression differentially through the action of its various functional domains. ADAM15 may downregulate adhesion of tumor cells to the extracellular matrix, reduce cell-cell adhesion, and promote metastasis through the activity of its disintegrin and metalloproteinase domains. Additionally, ADAM15 can influence cell signaling by shedding membrane-bound growth factors and other proteins that interact with receptor tyrosine kinases, leading to receptor activation. There is also evidence supporting a role for ADAM15 in angiogenesis and angioinvasion of tumor cells, which are critical for unrestrained tumor growth and metastatic spread. Given its diverse functions, ADAM15 may represent a pivotal regulatory component of tumor progression, an important target for therapeutic intervention, or emerge as a biomarker of disease progression.
Copyright 2009 Wiley-Liss, Inc.
Similar articles
-
Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.Biochem J. 2009 Apr 28;420(1):105-13. doi: 10.1042/BJ20082127. Biochem J. 2009. PMID: 19207106
-
ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.Thromb Haemost. 2005 Sep;94(3):555-61. doi: 10.1160/TH04-12-0784. Thromb Haemost. 2005. PMID: 16268472
-
ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.Int J Biochem Cell Biol. 2008;40(10):2164-73. doi: 10.1016/j.biocel.2008.02.021. Epub 2008 Feb 26. Int J Biochem Cell Biol. 2008. PMID: 18387333
-
Breaking up the tie: disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion.Pharmacol Ther. 2006 Sep;111(3):985-1006. doi: 10.1016/j.pharmthera.2006.02.009. Epub 2006 Apr 19. Pharmacol Ther. 2006. PMID: 16626807 Review.
-
Signal transduction by focal adhesion kinase in cancer.Cancer Metastasis Rev. 2009 Jun;28(1-2):35-49. doi: 10.1007/s10555-008-9165-4. Cancer Metastasis Rev. 2009. PMID: 19169797 Review.
Cited by
-
MicroRNA-147b regulates vascular endothelial barrier function by targeting ADAM15 expression.PLoS One. 2014 Oct 15;9(10):e110286. doi: 10.1371/journal.pone.0110286. eCollection 2014. PLoS One. 2014. PMID: 25333931 Free PMC article.
-
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.PLoS One. 2016 Mar 1;11(3):e0150138. doi: 10.1371/journal.pone.0150138. eCollection 2016. PLoS One. 2016. PMID: 26930657 Free PMC article.
-
Insights into the Evolutionary Dynamics: Characterization of Disintegrin and Metalloproteinase Proteins in the Venom Gland Transcriptome of the Hemiscorpius lepturus Scorpion.Protein Pept Lett. 2024;31(8):639-656. doi: 10.2174/0109298665321842240819073453. Protein Pept Lett. 2024. PMID: 39219422
-
ADAM15 protein amplifies focal adhesion kinase phosphorylation under genotoxic stress conditions.J Biol Chem. 2012 Jun 15;287(25):21214-23. doi: 10.1074/jbc.M112.347120. Epub 2012 Apr 27. J Biol Chem. 2012. PMID: 22544741 Free PMC article.
-
Components of cell-matrix linkage as potential new markers for prostate cancer.Cancers (Basel). 2011 Feb 25;3(1):883-96. doi: 10.3390/cancers3010883. Cancers (Basel). 2011. PMID: 24212644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
